Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder

A method of treating, preventing, reducing the occurrence of, decreasing the symptoms associated with, and reducing secondary recurrences of breast cancer, prostate cancer, colon cancer, lung cancer, and bladder cancer, comprising:

• administering to a subject in need thereof an orally administrable composition,
• the orally administrable composition including a broccoli extract or powder and one or both of a maitake and a shiitake mushroom extract or powder, and
• the orally administrable composition being formulated to provide synergistically effective amounts of one or both of a sulforaphane and/or a sulforaphane precursor and one or more glucans.

A method of treating, preventing, reducing the occurrence of, decreasing the symptoms associated with, and/or reducing secondary recurrences of a disease or condition associated with elevated levels of quinone estrogen in a subject in need thereof, comprising:

• administering to the subject in need thereof an orally administrable composition,
• the orally administrable composition including a broccoli extract or powder and one or both of a maitake and a shiitake mushroom extract or powder, and
• the orally administrable composition being formulated to provide synergistically effective amounts of one or both of a sulforaphane and/or a sulforaphane precursor and one or more glucans.

A method of increasing levels or increasing gene expression of NAD(P)H:quinone oxidoreductase 1 (NQO-1) in a subject in need thereof, comprising:

• administering to the subject an orally administrable composition,
• the orally administrable composition including sulforaphane or a derivative thereof and one or both of a maitake and a shiitake mushroom extract or powder, and
• the orally administrable composition being formulated to provide synergistically effective amounts of one or both of a sulforaphane and/or a sulforaphane precursor and one or more glucans.

A method of treating, preventing, reducing the occurrence of, decreasing the symptoms associated with, and/or reducing secondary recurrences of a disease or condition associated with elevated levels of quinone estrogen in a subject in need thereof, comprising:

• administering to the subject an orally administrable composition, orally administrable composition including sulforaphane or a derivative thereof and one or both of a maitake and a shiitake mushroom extract or powder, and
• the orally administrable composition being formulated to provide synergistically effective amounts of one or both of a sulforaphane and/or a sulforaphane precursor and one or more glucans.

A method of treating, preventing, reducing the occurrence of, decreasing the symptoms associated with, and/or reducing secondary recurrences of breast cancer, prostate cancer, colon cancer, lung cancer, and bladder cancer in a subject in need thereof, comprising:

• administering to the subject an orally administrable composition,
• the orally administrable composition including sulforaphane or a derivative thereof and one or both of a maitake and a shiitake mushroom extract or powder, and
• the orally administrable composition being formulated to provide synergistically effective amounts of one or both of a sulforaphane and/or a sulforaphane precursor and one or more glucans.